Skip Navigation


JAC Advance Access originally published online on July 21, 2009
Journal of Antimicrobial Chemotherapy 2009 64(4):821-823; doi:10.1093/jac/dkp261
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
64/4/821    most recent
dkp261v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sauermann, R.
Right arrow Articles by Zeitlinger, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sauermann, R.
Right arrow Articles by Zeitlinger, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Cerebrospinal fluid impairs antimicrobial activity of fosfomycin in vitro

Robert Sauermann1,*, Richard Schwameis1, Manfred Fille2, Maria Luciana Camuz Ligios1 and Markus Zeitlinger1

1 Department of Clinical Pharmacology, Section of Molecular Pharmacokinetics and Imaging, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria 2 Department of Hygiene, Microbiology and Social Medicine, Innsbruck Medical University, Fritz-Pregl-Straße 3, 6020 Innsbruck, Austria

Received 4 March 2009; returned 20 May 2009; revised 29 May 2009; accepted 29 June 2009

* Corresponding author. Tel: +43-1-40400-2981; Fax: +43-1-40400-2998; E-mail: robert.sauermann{at}meduniwien.ac.at

Objectives: Fosfomycin penetrates well into cerebrospinal fluid (CSF) and is considered for treatment of infections of the central nervous system (CNS). This study evaluated the influence of human CSF on the antimicrobial activity of fosfomycin.

Methods: Time–kill curves were performed in Mueller–Hinton broth (MHB) and in pooled human CSF using fosfomycin concentrations ranging from 0.25x to 8x MIC for a clinical Staphylococcus aureus isolate. To estimate the activity of fosfomycin at the target site, the concentration–time curve measured in CSF of a patient at steady state was simulated in vitro in human CSF using two S. aureus isolates.

Results: In CSF a higher fosfomycin concentration (8x MIC) was required to achieve sustained bacterial killing than in MHB (1x MIC). In vitro simulation of the pharmacokinetic profile measured in CSF of the selected patient showed initial killing, but terminal re-growth of both test strains.

Conclusions: The antibacterial activity of fosfomycin is lower in CSF than in MHB, and drug concentrations slightly exceeding the MIC may not be sufficient to achieve bactericidal effects in the CNS.

Keywords: CSF , time–kill curves , PK/PD simulation , pH , CO2


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.